Mutations of the EPHB6 receptor tyrosine kinase induce a pro-metastatic phenotype in non-small cell lung cancer (Q30528942)

13 October 2017

Mutations of the EPHB6 receptor tyrosine kinase induce a pro-metastatic phenotype in non-small cell lung cancer (English)

1 reference

13 October 2017

1 reference

Steffen Koschmieder

1 reference

ORCID Public Data File 2021

Carsten Müller-Tidow

object named as

Carsten Müller-Tidow

0 references

author name string

Etmar Bulk

1 reference

13 October 2017

Jun Yu

1 reference

13 October 2017

Antje Hascher

1 reference

13 October 2017

Rainer Wiewrodt

1 reference

13 October 2017

Utz Krug

1 reference

13 October 2017

Bernd Timmermann

1 reference

13 October 2017

Alessandro Marra

1 reference

13 October 2017

Ludger Hillejan

1 reference

13 October 2017

Karsten Wiebe

1 reference

13 October 2017

Wolfgang E Berdel

1 reference

13 October 2017

Albrecht Schwab

1 reference

13 October 2017

language of work or name

English

0 references

publication date

4 December 2012

1 reference

13 October 2017

1 reference

13 October 2017

1 reference

13 October 2017

1 reference

13 October 2017

e44591

1 reference

Creative Commons Attribution 4.0 International

13 October 2017

start time

4 December 2012

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

describes a project that uses

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC3514309/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514309

The EPHB6 receptor tyrosine kinase is a metastasis suppressor that is frequently silenced by promoter DNA hypermethylation in non-small cell lung cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514309

Eph receptors and ephrins in cancer: bidirectional signalling and beyond

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514309

The EphB6 receptor cooperates with c-Cbl to regulate the behavior of breast cancer cells

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514309

Role of tyrosine kinase inhibitors in lung cancer.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514309

Gene expression profiling and non-small-cell lung cancer: where are we now?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514309

EphB6 receptor significantly alters invasiveness and other phenotypic characteristics of human breast carcinoma cells

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514309

EGFR-targeted therapies in lung cancer: predictors of response and toxicity

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514309

Somatic mutations affect key pathways in lung adenocarcinoma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514309

The Eph receptor/ephrin system: an emerging player in the invasion game.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514309

20 June 2018

EPH receptors in cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514309

Dynamics of single potassium channel proteins in the plasma membrane of migrating cells

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514309

Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514309

Patterns of somatic mutation in human cancer genomes

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514309

Transcriptional silencing of EphB6 receptor tyrosine kinase in invasive breast carcinoma cells and detection of methylated promoter by methylation specific PCR.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514309

Biphasic functions of the kinase-defective Ephb6 receptor in cell adhesion and migration

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514309

RGS2 is an important target gene of Flt3-ITD mutations in AML and functions in myeloid differentiation and leukemic transformation.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514309

Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514309

Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514309

Loss of EphB6 expression in metastatic melanoma.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514309

Ephrin-A6, a new ligand for EphA receptors in the developing visual system

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514309

Unified nomenclature for Eph family receptors and their ligands, the ephrins. Eph Nomenclature Committee

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514309

Prognostic factors in NSCLC. Recent experiences

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514309

Unified Nomenclature for Eph Family Receptors and Their Ligands, the Ephrins

20 June 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0044591

Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0044591

Somatic mutations and germline sequence variants in patients with familial colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0044591

An efficient and economic enhancer mix for PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0044591

Prognostic significance ofEPHB6, EFNB2, andEFNB3 expressions in neuroblastoma

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23226491

12 December 2020

inferred from PubMed ID database lookup

Association among EPHB2, TrkA, and MYCN expression in low-stage neuroblastomas

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23226491

12 December 2020

inferred from PubMed ID database lookup

High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23226491

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1371/JOURNAL.PONE.0044591

1 reference

13 October 2017

0 references

1 reference

13 October 2017

PubMed publication ID

23226491

1 reference